 | Raymond James Reiterates "C$10.25" Price Target for Knight Therapeutics (TSE:GUD)
www.americanbankingnews.com - July 18 at 2:27 PM |
 | Medison Biotech Considers Requisition of Special Meeting of Shareholders of Knight Therapeutics Inc.
finance.yahoo.com - July 18 at 12:05 PM |
| Insider Buying: Knight Therapeutics Inc (TSE:GUD) Director Purchases 20,000 Shares of Stock
www.americanbankingnews.com - July 15 at 11:38 AM |
| Medison Biotech: Jonathan Goodman Takes Advantage of His Own Failure to Create Value, Enriching Himself at the Expense of the Shareholders of Knight Therapeutics
finance.yahoo.com - July 9 at 11:34 AM |
| Knight Announces Filing of New Drug Submission for Ibsrela™ in Canada
finance.yahoo.com - June 26 at 11:31 AM |
| Knight has less skin in Medimetriks through full loan repayment
finance.yahoo.com - June 18 at 6:19 PM |
| Is Knight Therapeutics Inc.'s (TSE:GUD) CEO Being Overpaid?
finance.yahoo.com - June 7 at 7:52 PM |
| Knight to Present at the Jefferies 2019 Global Healthcare Conference in New York City
finance.yahoo.com - May 29 at 11:16 AM |
 | Canada’s Most Undervalued Pharmaceutical Stock Is a Buy!
www.msn.com - May 24 at 4:05 PM |
| Knight to Present at the National Bank Financial Markets 9th Annual Quebec Conference in Toronto
finance.yahoo.com - May 23 at 4:08 PM |
| Knight to Present at the 2019 RBC Capital Markets Global Healthcare Conference in New York City
finance.yahoo.com - May 15 at 9:07 PM |
| Edited Transcript of GUD.TO earnings conference call or presentation 9-May-19 12:30pm GMT
finance.yahoo.com - May 10 at 4:06 PM |
| Notice of Knight Therapeutics' First Quarter 2019 Results Conference Call
finance.yahoo.com - May 2 at 11:49 AM |
| What Type Of Shareholder Owns Knight Therapeutics Inc.'s (TSE:GUD)?
finance.yahoo.com - May 1 at 4:01 PM |
| Medison Urges Knight Shareholders to Demand Answers to Critical Questions from Jonathan Goodman at the Bloom Burton & Co. Healthcare Investor Conference
finance.yahoo.com - April 30 at 11:25 AM |
| Medison Urges Fellow Shareholders to Bring Positive Change to Knight Therapeutics by Voting for All Six of Medison's Highly Qualified Nominees at Upcoming Annual Meeting
finance.yahoo.com - April 29 at 11:25 AM |
| Knight to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference in Toronto
finance.yahoo.com - April 26 at 11:29 AM |
 | Leading Independent Proxy Advisor, Key Shareholders, and More Analysts Back Jonathan Goodman’s Knight, Recommend Meir ...
www.globenewswire.com - April 25 at 4:02 PM |
| Leading Independent Proxy Advisor, Key Shareholders, and More Analysts Back Jonathan Goodman’s Knight, Recommend Meir Jakobsohn Not be Re-elected to the Board
finance.yahoo.com - April 25 at 4:02 PM |
| Medison Issues Presentation to Knight Shareholders
finance.yahoo.com - April 18 at 12:17 PM |
| Leading Canadian Corporate Governance Expert Confirms Acute Board Conflicts and Governance Deficiencies at Knight Therapeutics
finance.yahoo.com - April 17 at 10:13 AM |
 | Knight Therapeutics: Use of PROBUPHINE(TM) for Opioid Disorder Gains Momentum Across Canada; Subdermal Implant Now in Use from Coast to Coast
www.marketwatch.com - April 12 at 6:40 PM |
| Knight Therapeutics: Use of PROBUPHINE™ for Opioid Disorder Gains Momentum Across Canada; Subdermal Implant Now in Use from Coast to Coast
finance.yahoo.com - April 12 at 6:40 PM |
| Knight Receives Unanimous Support from Independent Analysts for Director Nominees, Current Strategy
finance.yahoo.com - April 10 at 9:08 PM |
| Medison Disappointed that Knight Therapeutics has Resorted to Blatant Misrepresentations to Avoid Scrutiny
finance.yahoo.com - April 10 at 4:08 PM |
| Knight Therapeutics Continues to Demonstrate Winning Strategy; Files Investor Presentation, Launches Microsite
finance.yahoo.com - April 8 at 10:29 AM |
| Medison Files Proxy Circular, Offers Knight Therapeutics Shareholders Truly Independent, Unconflicted Directors and Comprehensive Business Plan to Fix a Failing Knight
finance.yahoo.com - April 8 at 10:29 AM |
| Knight Files Management Information Circular, Warns Shareholders of Activist Jakobsohn’s Self-Interested Agenda
finance.yahoo.com - April 4 at 12:09 PM |
| Edited Transcript of GUD.TO earnings conference call or presentation 14-Mar-19 12:30pm GMT
finance.yahoo.com - March 16 at 12:10 PM |
| Notice of Knight Therapeutics' 2018 Fourth Quarter and Year End Results Conference Call
finance.yahoo.com - March 8 at 12:15 PM |
| Knight Therapeutics Comments on Flawed Accusations by Disgruntled Board Member; Remains Committed to Executing Strategy that is Working
finance.yahoo.com - March 1 at 12:12 PM |
| Knight Therapeutics Investor Presses for CEO to Cut Family Ties
finance.yahoo.com - February 28 at 3:59 PM |
| Are Knight Therapeutics Inc.’s (TSE:GUD) Interest Costs Too High?
finance.yahoo.com - February 21 at 1:23 PM |
| Based On Its ROE, Is Knight Therapeutics Inc. (TSE:GUD) A High Quality Stock?
finance.yahoo.com - January 22 at 11:06 AM |
 | A brain-damaged CEO has a hot new venture—and investors are piling in
www.theglobeandmail.com - January 21 at 8:46 AM |
| Did Knight Therapeutics Inc. (TSE:GUD) Insiders Sell Shares?
finance.yahoo.com - December 20 at 11:01 AM |
| Edited Transcript of GUD.TO earnings conference call or presentation 8-Nov-18 1:30pm GMT
finance.yahoo.com - November 9 at 11:07 AM |
| Do Institutions Own Knight Therapeutics Inc (TSE:GUD) Shares?
finance.yahoo.com - November 8 at 3:33 PM |
| Today's Research Reports on Knight Therapeutics, Covalon Technologies, Titan Medical and Neovasc
finance.yahoo.com - October 29 at 9:15 AM |
| A Look At Knight Therapeutics Inc (TSE:GUD) And The Healthcare Sector
finance.yahoo.com - October 4 at 3:24 PM |
| Jaguar Health's stock triples after licensing deal, has been halted 13 times for volatility
finance.yahoo.com - September 25 at 3:24 PM |
| Knight to Present at the Cantor Fitzgerald Global Healthcare Conference in New York City
finance.yahoo.com - September 25 at 9:51 AM |
| TTNP: First Internal Sales of Probuphine
finance.yahoo.com - September 7 at 3:23 PM |
| Knight to Participate at the Morgan Stanley Global Healthcare Conference in New York City
finance.yahoo.com - September 6 at 9:40 AM |
| What Investors Should Know About Knight Therapeutics Inc’s (TSE:GUD) Financial Strength
finance.yahoo.com - September 4 at 3:24 PM |
| Knight Disposes of a Toddler-Sized Amount of Pediapharm Inc.
finance.yahoo.com - September 1 at 9:34 AM |
| Today's Research Reports on Knight Therapeutics, Covalon Technologies, Cotinga Pharmaceuticals and Baylin Technologies
finance.yahoo.com - August 27 at 9:48 AM |
| Edited Transcript of GUD.TO earnings conference call or presentation 9-Aug-18 12:30pm GMT
finance.yahoo.com - August 10 at 8:58 AM |
| Knight Therapeutics Reports Second Quarter 2018 Results
finance.yahoo.com - August 9 at 9:09 AM |
 | 5 Reasons Why This Pharma Stock Is Poised for Takeoff
www.fool.ca - August 4 at 3:22 PM |
